This inventor holds 2 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1978-1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978-1985
Title: Rolf Studer: Innovator in Pharmaceutical Synthesis
Introduction
Rolf Studer is a notable inventor based in Bottmingen, Switzerland. He has made significant contributions to the field of pharmaceutical synthesis, holding two patents that showcase his innovative approach to drug development.
Latest Patents
Studer's latest patents include the synthesis of thymosin .alpha..sub.1 and desacetyl thymosin .alpha..sub.1. This patent describes an improved solution phase synthesis method that utilizes t-Boc side chain protection and novel intermediates. Another important patent involves L-pyroglutamyl-L-histidyl-L-prolyl-beta-alaninamide and its acid addition salts, which are recognized for their potential as anti-depressant agents.
Career Highlights
Rolf Studer has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has contributed to advancements in therapeutic agents, particularly in the area of mental health.
Collaborations
Throughout his career, Studer has collaborated with esteemed colleagues such as Dieter Gillessen and Arnold Trzeciak. These partnerships have fostered a collaborative environment that enhances innovation and research.
Conclusion
Rolf Studer exemplifies the spirit of innovation in pharmaceutical synthesis, with patents that reflect his commitment to advancing medical science. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile